arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

BeOne Medicines Ltd.

ONC
$348.52 ▲ +18.52 (+5.61%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
47 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
68
Health
Good
Neutral
auto_awesome

Analytical Summary

BeOne Medicines Ltd. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $502.7B
Dividend Yield
Revenue Growth 35.5%
Op. Margin 16.5%
ROIC 3.9%
FCF / Share $0.11
Trailing P/E 2178.3x
Price / Book 105.8x
FCF Yield 0.0%
Debt / Equity 0.18
info Valuation on last close. End-of-day price, Aug 7, 2026.

47-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.51B
↑ +35.5%
Net Income Profit after all expenses
$227.36M
↑ +17802.1%
Operating Margin Operating profit as % of sales
16.5%
↑ +33.7% 52th
FCF / Share Free cash flow per share
$0.11
↓ -55.0%
Long-Term Debt Long-term obligations
$842.92M
↑ +0.8%

Health Breakdown

Profitability
60
Returns
57
Financial Health
77
Cash Quality
92

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 47 quarters